GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Operating Cash Flow per Share

Bio-Techne (BSP:T1CH34) Operating Cash Flow per Share : R$0.28 (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Operating Cash Flow per Share?

Bio-Techne's operating cash flow per share for the three months ended in Dec. 2023 was R$0.09. Bio-Techne's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was R$0.28.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bio-Techne was -5.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Bio-Techne's Operating Cash Flow per Share or its related term are showing as below:

BSP:T1CH34' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -1.8   Med: 13.1   Max: 57.1
Current: 6.5

During the past 13 years, Bio-Techne's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.10% per year. The lowest was -1.80% per year. And the median was 13.10% per year.

BSP:T1CH34's 3-Year OCF Growth Rate is ranked better than
53.02% of 1241 companies
in the Biotechnology industry
Industry Median: 3.7 vs BSP:T1CH34: 6.50

Bio-Techne Operating Cash Flow per Share Historical Data

The historical data trend for Bio-Techne's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Operating Cash Flow per Share Chart

Bio-Techne Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.23 0.37 0.33 0.25

Bio-Techne Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.05 0.08 0.06 0.09

Competitive Comparison of Bio-Techne's Operating Cash Flow per Share

For the Biotechnology subindustry, Bio-Techne's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Price-to-Operating-Cash-Flow falls into.



Bio-Techne Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Bio-Techne's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )=Cash Flow from Operations (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=1234.747/4855.650
=0.25

Bio-Techne's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=407.252/4801.800
=0.08

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Techne Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Techne (BSP:T1CH34) Business Description

Industry
Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines